GenSight Biologics Updates Real-World Data on LUMEVOQ® at NANOS 2024

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a prominent biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has disclosed recent prospective real-world data from early access programs (EAP) affirming the efficacy…

Read MoreGenSight Biologics Updates Real-World Data on LUMEVOQ® at NANOS 2024

Haemonetics to Acquire Attune Medical: Definitive Agreement Confirmed

Haemonetics Corporation (NYSE: HAE), a leading global medical technology firm dedicated to enhancing patient outcomes, has revealed its definitive agreement to acquire Attune Medical, a Chicago-based private company renowned for producing the ensoETM® proactive esophageal cooling device. This device, the…

Read MoreHaemonetics to Acquire Attune Medical: Definitive Agreement Confirmed

Dermavant to Present New ADORING Data on VTAMA® Cream for Atopic Dermatitis at 2024 AAD Meeting

Dermavant Sciences to Present New ADORING Data on Tapinarof Cream for Atopic Dermatitis at 2024 AAD Annual Meeting Dermavant Sciences, a biopharmaceutical company specializing in innovative therapies for immuno-dermatology, will unveil new ADORING data at the 2024 American Academy of…

Read MoreDermavant to Present New ADORING Data on VTAMA® Cream for Atopic Dermatitis at 2024 AAD Meeting

Sunflower Health Plan, Centene Foundation, KU Endowment Grant $500K to Kansas Nursing Workforce Center

Sunflower Health Plan (Sunflower), a managed care organization dedicated to providing quality healthcare services in Kansas and a wholly owned subsidiary of the Centene Corporation (NYSE: CNC), along with the Centene Foundation and KU Endowment, have announced a significant partnership.…

Read MoreSunflower Health Plan, Centene Foundation, KU Endowment Grant $500K to Kansas Nursing Workforce Center